Xellia Pharmaceuticals

Xellia Pharmaceuticals is the global leader in fermentation-based non-beta-lactam anti-infectives. We manufacture and supply Active Pharmaceutical Ingredients (APIs) as well as Finished Dosage Forms (FDFs) to over 500 pharmaceutical companies across 80 countries.

The European Union and the World Health Organization recognize a variety of our products as essential and critical medicines, serving as crucial resources in the fight against severe infections and antimicrobial resistance.

Headquartered in Denmark, Xellia Pharmaceuticals boasts a global footprint, with manufacturing sites in Copenhagen, Denmark; Budapest, Hungary; and Taizhou, China, alongside R&D and commercial operations in an additional seven locations around the world. We stand as the sole European manufacturer of several of our products and possess a rich legacy of over 120 years in the pharmaceutical industry.